LIXT

3.99

1.48% -0.06

Dopo l'orario di chiusura: 3.99

Lixte Biotechnology Holdings Inc (LIXT)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$4.05

Aprire:

$4.14

Volume 24 ore:

45,190

Relative Volume:

0.41

Capitalizzazione di mercato:

$25.02M

Reddito:

Utile/perdita netta:

$-4.69M

Rapporto P/E:

-1.7124

EPS:

-2.33

Flusso di cassa netto:

$-3.81M

1 W Prestazione:

-8.06%

1M Prestazione:

-4.77%

6M Prestazione:

+250.00%

1 anno Prestazione:

+101.00%

Intervallo 1D:

$3.95

$4.15

Intervallo di 1 settimana:

$3.95

$4.40

Portata 52W:

$0.64

$6.26

Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile

Nome

Lixte Biotechnology Holdings Inc

Settore

Healthcare (1131)

Industria

Biotechnology (631)

Telefono

310 203 2902

Indirizzo

433 PLAZA REAL, BOCA RATON

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

LIXT's Discussions on Twitter

Confronta LIXT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LIXT Lixte Biotechnology Holdings Inc	3.99	25.40M	0	-4.69M	-3.81M	-2.33
VRTX Vertex Pharmaceuticals Inc	455.71	114.69B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	752.62	77.91B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	850.95	54.05B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	391.50	52.52B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	196.92	42.02B	447.02M	-1.18B	-906.14M	-6.1812

Lixte Biotechnology Holdings Inc Borsa (LIXT) Ultime notizie

Dec 11, 2025

Lixte Biotechnology shareholders approve board nominees and stock plan amendment - Investing.com

Dec 11, 2025

Lixte Biotechnology shareholders approve board nominees and stock plan amendment By Investing.com - Investing.com South Africa

Dec 11, 2025

Lixte Biotechnology Holds Annual Meeting, Approves Key Issues - TipRanks

Dec 11, 2025

Dec 09, 2025

Lixte’s Big Bet: Making Other Cancer Drugs Work Harder - InvestorNews

Dec 09, 2025

Dec 08, 2025

LIXTE (NASDAQ: LIXT) expands oncology platform with LiGHT proton therapy system - Stock Titan

Dec 08, 2025

Dec 06, 2025

Lixte Biotechnology (LIXT) Stock Analysis Report | Financials & Insights - Benzinga

Dec 06, 2025

Meme Stocks: Will Lixte Biotechnology Holdings Inc stock maintain momentum in 2025Quarterly Trade Report & Free Weekly Watchlist of Top Performers - moha.gov.vn

Dec 06, 2025

Dec 05, 2025

Lixte Biotechnology shares slide following purchase of UK-based Liora - MSN

Dec 05, 2025

Is Lixte Biotechnology Holdings Inc. (8640) stock a buy on weaknessWeekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser

Dec 05, 2025

Will Lixte Biotechnology Holdings Inc. stock maintain momentum in 2025Market Trend Summary & Daily Oversold Stock Bounce Ideas - Newser

Dec 05, 2025

Dec 04, 2025

What sentiment indicators say about Lixte Biotechnology Holdings Inc. stockJuly 2025 EndofMonth & Fast Momentum Entry Tips - Newser

Dec 04, 2025

Is Lixte Biotechnology Holdings Inc. (8640) stock undervalued historicallyQuarterly Trade Summary & Real-Time Volume Surge Alerts - Newser

Dec 04, 2025

Can Lixte Biotechnology Holdings Inc. stock deliver consistent earnings growthJuly 2025 Closing Moves & Free Community Supported Trade Ideas - Newser

Dec 04, 2025

Published on: 2025-12-04 00:03:12 - Newser

Dec 04, 2025

Dec 03, 2025

LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology - Yahoo Finance

Dec 03, 2025

LIXTE (NASDAQ: LIXT) advances LB-100 combos with GSK, Roche and refines long-term strategy - Stock Titan

Dec 03, 2025

LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers - Yahoo Finance

Dec 03, 2025

Will Lixte Biotechnology Holdings Inc. (8640) stock rise with strong economy2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser

Dec 03, 2025

Nov 27, 2025

There is no doubt that Lixte Biotechnology Holdings Inc (LIXT) ticks all the boxes. - Setenews

Nov 27, 2025

Nov 25, 2025

Lixte Biotechnology Acquires Liora Technologies for Growth - TipRanks

Nov 25, 2025

LIXTE Biotechnology acquires UK-based proton therapy developer Liora By Investing.com - Investing.com Nigeria

Nov 25, 2025

Lixte Biotechnology stock falls after acquiring UK-based Liora By Investing.com - Investing.com

Nov 25, 2025

Lixte Biotechnology stock falls after acquiring UK-based Liora - Investing.com

Nov 25, 2025

LIXTE Biotechnology (LIXT) Expands with Acquisition of Liora Tec - GuruFocus

Nov 25, 2025

LIXTE Biotechnology acquires UK-based proton therapy developer Liora - Investing.com India

Nov 25, 2025

LIXTE Biotechnology Holdings, Inc. Completes Acquisition of Liora Technologies Europe Ltd. to Advance Proton Therapy Treatment for Cancer - Quiver Quantitative

Nov 25, 2025

LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment - InvestorNews

Nov 25, 2025

S&P 500, Dow and NASDAQ end day on positive note as Wall Street begins Thanksgiving week on high with boos - The Economic Times

Nov 25, 2025

Nov 24, 2025

Lixte Biotechnology announces $5M equity financing; shares down - MSN

Nov 24, 2025

Nov 23, 2025

Will Upside Catalysts Materialize for Vallabh Steels Limited in YEARGrowth Stock Opportunities & Small Capital Investment Tips - earlytimes.in

Nov 23, 2025

Nov 21, 2025

Earlyworks shareholders reject share issuance for acquisition, approve new directors and warrants By Investing.com - Investing.com Australia

Nov 21, 2025

Earlyworks shareholders reject share issuance for acquisition, approve new directors and warrants - Investing.com UK

Nov 21, 2025